The trademark application TOLLOVID was filed by Todos Medical USA, a U.S. corporation (the "Applicant"). The application was published for oppositions on June 1, 2021, and it was registered by office on September 8, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).